Your browser doesn't support javascript.
loading
Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors.
Rudaka, Irina; Vilne, Baiba; Isakova, Jekaterina; Kalejs, Oskars; Gailite, Linda; Rots, Dmitrijs.
Afiliação
  • Rudaka I; Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia.
  • Vilne B; Latvian Cardiology Centre, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
  • Isakova J; Bioinformatics Laboratory, Riga Stradins University, LV-1007 Riga, Latvia.
  • Kalejs O; Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia.
  • Gailite L; Latvian Cardiology Centre, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
  • Rots D; Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia.
J Cardiovasc Dev Dis ; 10(3)2023 Feb 28.
Article em En | MEDLINE | ID: mdl-36975868
BACKGROUND: Atrial fibrillation (AF) is the most common arrhythmia and typically occurs in elderly patients with other cardiovascular and extracardiac diseases. However, up to 15% of AF develops without any related risk factors. Recently, the role of genetic factors has been highlighted in this particular form of AF. AIMS: The aims of this study were to determine the prevalence of pathogenic variants in early-onset AF in patients without known disease-related risk factors and to identify any structural cardiac abnormalities in these patients. MATERIALS AND METHODS: We conducted exome sequencing and interpretation in 54 risk factor-free early-onset AF patients and further validated our findings in a similar AF patient cohort from the UK Biobank. RESULTS: Pathogenic/likely pathogenic variants were found in 13/54 (24%) patients. The variants were identified in cardiomyopathy-related and not arrhythmia-related genes. The majority of the identified variants were TTN gene truncating variants (TTNtvs) (9/13 (69%) patients). We also observed two TTNtvs founder variants in the analysed population-c.13696C>T p.(Gln4566Ter) and c.82240C>T p.(Arg27414Ter). Pathogenic/likely pathogenic variants were found in 9/107 (8%) individuals from an independent similar AF patient cohort from the UK Biobank. In correspondence with our Latvian patients, only variants in cardiomyopathy-associated genes were identified. In five (38%) of the thirteen Latvian patients with pathogenic/likely pathogenic variants, dilation of one or both ventricles was identified on a follow-up cardiac magnetic resonance scan. CONCLUSIONS: We observed a high prevalence of pathogenic/likely pathogenic variants in cardiomyopathy-associated genes in patients with risk factor-free early-onset AF. Moreover, our follow-up imaging data indicate that these types of patients are at risk of developing ventricular dilation. Furthermore, we identified two TTNtvs founder variants in our Latvian study population.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cardiovasc Dev Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Letônia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cardiovasc Dev Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Letônia País de publicação: Suíça